Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan

Shiu Feng Huang; Yhu Chering Huang; Feng Yee Chang; Jung Chung Lin; Chun Hsiang Chiu; Chien Wen Chen; Fu Der Wang; Yen Ling Chiu; Shu Hsing Cheng; Chien Yu Cheng; Yi Chun Lin; Cheng Pin Chen; Chien Hsien Huang; Po Yu Liu; Yuan Ti Lee; Chen Hsiang Lee; Yao Shen Chen; Cheng Len Sy; Yu Ting Tseng; Cheng Ting Hsu; Chia Chun Tseng; Yu Lin Lee; Chun Eng Liu; Huey Kang Sytwu

doi:10.1016/j.bj.2020.05.018

Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan

Shiu Feng Huang^*, Yhu Chering Huang, Feng Yee Chang, Jung Chung Lin, Chun Hsiang Chiu, Chien Wen Chen, Fu Der Wang, Yen Ling Chiu, Shu Hsing Cheng, Chien Yu Cheng, Yi Chun Lin, Cheng Pin Chen, Chien Hsien Huang, Po Yu Liu, Yuan Ti Lee, Chen Hsiang Lee, Yao Shen Chen, Cheng Len Sy, Yu Ting Tseng, Cheng Ting HsuChia Chun Tseng, Yu Lin Lee, Chun Eng Liu, Huey Kang Sytwu

^*Corresponding author for this work

Research output: Contribution to journal › Short survey › peer-review

16 Scopus citations

Abstract

By the request of the Minister of Health and Welfare, NHRI Biobank was assigned to establish a COVID-19 biobank in early Feb, 2020 to collect COVID-19 patients’ blood samples for Taiwan researchers and industries in an emergent way. It was set up in less than 3 weeks and quickly opened for application. By August 5, 2020, this COVID-19 biobank has collected 165 blood samples of 110 patients from more than 10 hospitals across north, middle and south part of Taiwan, including both COVID-19 (+) and (-) pneumonia patients. This biobank can provide applicants with biosamples, such as serum, DNA and RNA, and also the clinical and genomic data, so as to accelerate the COVID-19 treatment and prevention research in Taiwan. This COID-19 biobank already received 15 applications. It has become the most important research resource for the COVID-19 pandemic in Taiwan, including new screening reagents, disease mechanism, the variable human responses and epidemic preventions. Since it is publicly available for both academic and industrial applicants.

Original language	English
Pages (from-to)	314-317
Number of pages	4
Journal	Biomedical Journal
Volume	43
Issue number	4
DOIs	https://doi.org/10.1016/j.bj.2020.05.018
State	Published - 08 2020
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2020 Chang Gung University

Keywords

Biobank
COVID-19
Consortium
Pneumonia

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.bj.2020.05.018

Cite this

Huang, S. F., Huang, Y. C., Chang, F. Y., Lin, J. C., Chiu, C. H., Chen, C. W., Wang, F. D., Chiu, Y. L., Cheng, S. H., Cheng, C. Y., Lin, Y. C., Chen, C. P., Huang, C. H., Liu, P. Y., Lee, Y. T., Lee, C. H., Chen, Y. S., Sy, C. L., Tseng, Y. T., ... Sytwu, H. K. (2020). Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan. Biomedical Journal, 43(4), 314-317. https://doi.org/10.1016/j.bj.2020.05.018

@article{27e3cf244e164e888d05e9797972e371,

title = "Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan",

abstract = "By the request of the Minister of Health and Welfare, NHRI Biobank was assigned to establish a COVID-19 biobank in early Feb, 2020 to collect COVID-19 patients{\textquoteright} blood samples for Taiwan researchers and industries in an emergent way. It was set up in less than 3 weeks and quickly opened for application. By August 5, 2020, this COVID-19 biobank has collected 165 blood samples of 110 patients from more than 10 hospitals across north, middle and south part of Taiwan, including both COVID-19 (+) and (-) pneumonia patients. This biobank can provide applicants with biosamples, such as serum, DNA and RNA, and also the clinical and genomic data, so as to accelerate the COVID-19 treatment and prevention research in Taiwan. This COID-19 biobank already received 15 applications. It has become the most important research resource for the COVID-19 pandemic in Taiwan, including new screening reagents, disease mechanism, the variable human responses and epidemic preventions. Since it is publicly available for both academic and industrial applicants.",

keywords = "Biobank, COVID-19, Consortium, Pneumonia",

author = "Huang, \{Shiu Feng\} and Huang, \{Yhu Chering\} and Chang, \{Feng Yee\} and Lin, \{Jung Chung\} and Chiu, \{Chun Hsiang\} and Chen, \{Chien Wen\} and Wang, \{Fu Der\} and Chiu, \{Yen Ling\} and Cheng, \{Shu Hsing\} and Cheng, \{Chien Yu\} and Lin, \{Yi Chun\} and Chen, \{Cheng Pin\} and Huang, \{Chien Hsien\} and Liu, \{Po Yu\} and Lee, \{Yuan Ti\} and Lee, \{Chen Hsiang\} and Chen, \{Yao Shen\} and Sy, \{Cheng Len\} and Tseng, \{Yu Ting\} and Hsu, \{Cheng Ting\} and Tseng, \{Chia Chun\} and Lee, \{Yu Lin\} and Liu, \{Chun Eng\} and Sytwu, \{Huey Kang\}",

note = "Publisher Copyright: {\textcopyright} 2020 Chang Gung University",

year = "2020",

month = aug,

doi = "10.1016/j.bj.2020.05.018",

language = "英语",

volume = "43",

pages = "314--317",

journal = "Biomedical Journal",

issn = "2319-4170",

publisher = "Elsevier B.V.",

number = "4",

}

Huang, SF, Huang, YC, Chang, FY, Lin, JC, Chiu, CH, Chen, CW, Wang, FD, Chiu, YL, Cheng, SH, Cheng, CY, Lin, YC, Chen, CP, Huang, CH, Liu, PY, Lee, YT, Lee, CH, Chen, YS, Sy, CL, Tseng, YT, Hsu, CT, Tseng, CC, Lee, YL, Liu, CE & Sytwu, HK 2020, 'Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan', Biomedical Journal, vol. 43, no. 4, pp. 314-317. https://doi.org/10.1016/j.bj.2020.05.018

TY - JOUR

T1 - Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan

AU - Huang, Shiu Feng

AU - Huang, Yhu Chering

AU - Chang, Feng Yee

AU - Lin, Jung Chung

AU - Chiu, Chun Hsiang

AU - Chen, Chien Wen

AU - Wang, Fu Der

AU - Chiu, Yen Ling

AU - Cheng, Shu Hsing

AU - Cheng, Chien Yu

AU - Lin, Yi Chun

AU - Chen, Cheng Pin

AU - Huang, Chien Hsien

AU - Liu, Po Yu

AU - Lee, Yuan Ti

AU - Lee, Chen Hsiang

AU - Chen, Yao Shen

AU - Sy, Cheng Len

AU - Tseng, Yu Ting

AU - Hsu, Cheng Ting

AU - Tseng, Chia Chun

AU - Lee, Yu Lin

AU - Liu, Chun Eng

AU - Sytwu, Huey Kang

PY - 2020/8

Y1 - 2020/8

N2 - By the request of the Minister of Health and Welfare, NHRI Biobank was assigned to establish a COVID-19 biobank in early Feb, 2020 to collect COVID-19 patients’ blood samples for Taiwan researchers and industries in an emergent way. It was set up in less than 3 weeks and quickly opened for application. By August 5, 2020, this COVID-19 biobank has collected 165 blood samples of 110 patients from more than 10 hospitals across north, middle and south part of Taiwan, including both COVID-19 (+) and (-) pneumonia patients. This biobank can provide applicants with biosamples, such as serum, DNA and RNA, and also the clinical and genomic data, so as to accelerate the COVID-19 treatment and prevention research in Taiwan. This COID-19 biobank already received 15 applications. It has become the most important research resource for the COVID-19 pandemic in Taiwan, including new screening reagents, disease mechanism, the variable human responses and epidemic preventions. Since it is publicly available for both academic and industrial applicants.

AB - By the request of the Minister of Health and Welfare, NHRI Biobank was assigned to establish a COVID-19 biobank in early Feb, 2020 to collect COVID-19 patients’ blood samples for Taiwan researchers and industries in an emergent way. It was set up in less than 3 weeks and quickly opened for application. By August 5, 2020, this COVID-19 biobank has collected 165 blood samples of 110 patients from more than 10 hospitals across north, middle and south part of Taiwan, including both COVID-19 (+) and (-) pneumonia patients. This biobank can provide applicants with biosamples, such as serum, DNA and RNA, and also the clinical and genomic data, so as to accelerate the COVID-19 treatment and prevention research in Taiwan. This COID-19 biobank already received 15 applications. It has become the most important research resource for the COVID-19 pandemic in Taiwan, including new screening reagents, disease mechanism, the variable human responses and epidemic preventions. Since it is publicly available for both academic and industrial applicants.

KW - Biobank

KW - COVID-19

KW - Consortium

KW - Pneumonia

UR - https://www.scopus.com/pages/publications/85086506085

U2 - 10.1016/j.bj.2020.05.018

DO - 10.1016/j.bj.2020.05.018

M3 - 短篇评述

C2 - 32563697

AN - SCOPUS:85086506085

SN - 2319-4170

VL - 43

SP - 314

EP - 317

JO - Biomedical Journal

JF - Biomedical Journal

IS - 4

ER -

Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this